Effects of Different Physical Therapy Programs on Pulmonary Rehabilitation in Patients With Lung Cancer

June 3, 2021 updated by: Hao Long, Sun Yat-sen University
This study applies external diaphragm pacemaker and positive expiratory pressure therapy to patients who received thoracic surgeries, in order to explore the effects of different physical therapy programs on pulmonary rehabilitation in patients with lung cancer. As well as we hope that these physical training programs can effectively improve the lung function of patients, reduce postoperative pulmonary complications, hospitalization days, hospitalization expenses, etc.

Study Overview

Detailed Description

This study applies external diaphragm pacemaker and positive expiratory pressure therapy to patients who received thoracic surgeries, ninety patients may be enrolled in this study.

Some metrics are used to evaluate the pulmonary rehabilitation status in postoperative patients which include pulmonary function test, 6-Min Walking Test,Borg index, complications incidence, chest tube draining time, and diaphragm muscle mobility.

Study Type

Interventional

Enrollment (Anticipated)

90

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

    • Guangdong
      • Guangzhou, Guangdong, China
        • Recruiting
        • Sun Yat Sen University Cancer Center
        • Contact:
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 80 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  1. Patients who are diagnosed with non-small cell lung cancer with clear pathological cytology by fiberoptic bronchoscopy and CT, and plan to undergo lobectomy or segmentectomy under general anesthesia for tracheal intubation;
  2. Age 18-80 years old;
  3. Those who have stable vital signs and can participate in this research;
  4. Pulmonary function test FEV1/FVC>0.8.
  5. Volunteer to participate in this research and sign an informed consent form.

Exclusion Criteria:

  1. Pneumonectomy patients;
  2. Wedge resection patients
  3. Patients with distant metastasis of cancer;
  4. Patients with other malignant tumors;
  5. Severe complications occurred during the operation, and respiratory function training and testing are not allowed before and after Evaluator;
  6. Patients with severe physical or mental illness who cannot cooperate with the test;
  7. Patients with pacemakers, active tuberculosis, and pneumothorax.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Placebo Comparator: Regular ACBT training
Including quitting smoking, ACBT training, cough practicing.
Performed 5 days before surgery and one month after surgery, twice a day.
Experimental: Positive expiratory pressure therapy
Use acpella®PEP therapeutic system and regular nursing care.
Continuously instruct patients to perform positive expiratory pressure training 5 days before surgery and one month after surgery, twice a day.
Experimental: External diaphragm pacemaker
Patients are trained to use external diaphragm pacemaker and receive regular nursing care.
Use external diaphragm pacemaker to stimulate patients' diaphragms.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The change from baseline Forced Expiratory Volume In One Second at one month after surgery
Time Frame: baseline (before the surgery), and one month after surgery
Evaluate the change of Forced Expiratory Volume In One Second before the surgery and one month after surgery by conducting Pulmonary Function Test on resectable NSCLC patients
baseline (before the surgery), and one month after surgery

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
The change from baseline Borg Score at one month after surgery.
Time Frame: baseline (before the surgery), and one month after surgery
Borg Score is a rating of perceived exertion which is a reliable indicator to monitor and guide exercise intensity.It allows individuals to subjectively rate their level of exertion during exercise testing.We would record patients' Borg Score after 6 minutes walking test
baseline (before the surgery), and one month after surgery
Complications incidence
Time Frame: One month after surgery
Record the complications of patients after surgery.
One month after surgery

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 1, 2020

Primary Completion (Anticipated)

November 30, 2021

Study Completion (Anticipated)

December 30, 2021

Study Registration Dates

First Submitted

December 30, 2020

First Submitted That Met QC Criteria

June 3, 2021

First Posted (Actual)

June 4, 2021

Study Record Updates

Last Update Posted (Actual)

June 4, 2021

Last Update Submitted That Met QC Criteria

June 3, 2021

Last Verified

May 1, 2021

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Rehabilitation

Clinical Trials on ACBT training

3
Subscribe